MDL-202

N/A

Report date: 2025/08/29 17:06:02

Base Information

Drug NameMDL-202
Drug Alias NameMDL-202
ClassificationCell and gene therapy > Gene therapy > Gene editing > CRISPR
Mechanisms of ActionMyotonin-protein kinase inhibitors
TargetsMyotonin-protein kinase
Therapy Area/IndicationsMyotonic DystrophyMusculoskeletal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesModalis Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesModalis Therapeutics CorpAstellas Pharma IncModalis Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMyotonic DystrophyMusculoskeletal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A